Insphero, Inc.

Portland, ME Insphero Inc. Part of Insphero AG

UEI
FCCCVSMNHGJ6
CAGE
7WFG6
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
  • Insphero AG Parent SJC4FD6PQH65
    • Insphero, Inc. FCCCVSMNHGJ6
SAM.gov registration date
Physical address
770 Congress St, Portland, ME 04102, USA
Website
insphero.com
Founded
2009
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Insphero, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Insphero, INC.:1302435 [25-000250] Contract · 75N95025P00047 National Institute on Drug Abuse $46,830
Transcriptomics study RNA-SEQ in liver spheroids phase one Contract · 75N95024P00513 National Institute on Drug Abuse $96,830
Liver assay in liver spheroids for sirna/asos Contract · 75N95024P00430 National Institute on Drug Abuse $90,414
Insphero, INC.:1302435 [24-002322] Contract · 75N95024P00169 National Institute on Drug Abuse $22,800
3D liver microtissues compose of human primary hepatocytes and a mixture of human primary hepatocyte, liver… Contract · 75N95023P00311 National Institute on Drug Abuse $34,277

About Insphero, Inc.

Insphero Inc. is a foreign-owned, for-profit corporate entity registered in SAM.gov that specializes in advanced 3D cell culture technologies and in vitro biological models. Headquartered in Brunswick, Maine, the company is a subsidiary of Insphero AG and focuses on developing sophisticated cellular platforms for scientific research, particularly in drug testing and toxicity assessment. The company is primarily oriented toward providing specialized biological products to federal agencies, with a particular emphasis on creating complex, three-dimensional cellular models that can simulate human tissue environments for research purposes.

The federal contract awards demonstrate Insphero's expertise in producing highly specialized 3D liver microtissues and cellular models for scientific research, predominantly for agencies within the Department of Health and Human Services. Specifically, the company has been awarded multiple prime contracts from the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences (NCATS), with contract values ranging from $22,800 to $96,829.63. These contracts involve providing intricate 3D liver spheroids composed of human primary hepatocytes, liver endothelial cells, and Kupffer cells, which are used for critical research applications such as drug-induced liver injury assays, toxicity testing, viral infectivity studies, and safety assessments for emerging pharmaceutical compounds. Additionally, Insphero has received several subcontract awards from Battelle Memorial Institute, supporting the National Toxicology Program (NTP) and RETOX programs, further highlighting their specialized capabilities in creating advanced cellular research models.

Quick answers

What is Insphero, Inc.'s UEI?

Insphero, Inc.'s Unique Entity ID (UEI) in SAM.gov is FCCCVSMNHGJ6.

What is Insphero, Inc.'s CAGE code?

Insphero, Inc.'s CAGE code is 7WFG6.

What is Insphero, Inc.'s primary NAICS code?

Insphero, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).

Where is Insphero, Inc. located?

Insphero, Inc.'s physical address in SAM.gov is 770 Congress St, Portland, ME 04102, USA.

Is Insphero, Inc. registered in SAM.gov?

Yes. Insphero, Inc.'s SAM.gov registration is active through January 28, 2027.

Who is Insphero, Inc.'s parent company?

Insphero, Inc. is part of Insphero AG.

What is Insphero, Inc.'s most recent federal award?

Insphero, Inc.'s most recent federal contract award is Insphero, INC.:1302435 [25-000250] (75N95025P00047), from National Institute on Drug Abuse, on December 5, 2024.

On GovTribe

See Insphero, Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors